Skip to main content
Roger Hajjar, MD, Cardiology, New York, NY

Roger Joseph Hajjar MD


Professor, Medicine, Icahn School of Medicine

Join to view full profile
  • 1 Gustave L Levy PlNew York, NY 10029

  • Phone+1 212-427-1540

  • Fax+1 212-410-7196

Dr. Hajjar is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Cardiovascular Disease, 1993 - 1996
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1990 - 1993
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1992 - 2027
  • NY State Medical License
    NY State Medical License 2006 - 2019

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2005
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Original Investigation Editorial Comment Mitral Valve Prolapse: A Disease of Valve and Ventricle∗  
    Robert A Levine, Roger J Hajjar, ScienceDirect
  • Original Investigation Acute Left Ventricular Unloading Reduces Atrial Stretch and Inhibits Atrial Arrhythmias  
    Roger Hajjar, MD, ScienceDirect
  • Original Research Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury with Radiolabeled Duramycin Targeting Phosphatidylethanolamine: Effective Target Uptake...  
    Renu Virmani, Francis G Blankenberg, Roger J Hajjar, Navneet Narula, Harry W Strauss, ScienceDirect

Press Mentions

  • Mass General Brigham Researchers Awarded ARPA-H Funding to Scale Genome Editing for Rare Genetic Vascular Diseases
    Mass General Brigham Researchers Awarded ARPA-H Funding to Scale Genome Editing for Rare Genetic Vascular DiseasesJuly 21st, 2026
  • Heart-Targeting AAV Advances Cardiac Gene Therapy in First-in-Human Trial
    Heart-Targeting AAV Advances Cardiac Gene Therapy in First-in-Human TrialOctober 22nd, 2025
  • Gene Therapy for Heart Failure Demonstrates Safety and Efficacy in Phase 1 Trial
    Gene Therapy for Heart Failure Demonstrates Safety and Efficacy in Phase 1 TrialOctober 21st, 2025

Grant Support

  • Trip: Targeted Gene Therapy For The Treatment Of Heart FailureNational Heart, Lung, And Blood Institute2012
  • Gene Therapy With Cardiotropic Vectors For The Treatment Of Heart FailureNational Heart, Lung, And Blood Institute2010–2012
  • C-Trip: Targeted Gene Therapy For The Treatment Of Heart Failure (P20)National Heart, Lung, And Blood Institute2010–2011
  • Targeting Calcium Cycling In A Pre-Clinical Model Of Cardiac DysfunctionNational Heart, Lung, And Blood Institute2010
  • Regression Of Cardiac HypertrophyNational Heart, Lung, And Blood Institute2010

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: